slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 89,881-89,910
Pages 3,225
Rows per page 30
Component
89,881-89,910 of 96,741
10
The slide uses external media clippings (WSJ, Prime Video) as evidence of peer innovation.Blackwells Capital | Activist Presentation Deck | 22 slides · Blackwells Capital
Activist deck Activist investor Beat · Solution1 hit
13
The slide uses a metaphorical 'flywheel' concept to describe Disney's business model and suggests AI as a catalyst for speed.Blackwells Capital | Activist Presentation Deck | 22 slides · Blackwells Capital
Activist deck Activist investor Beat · Solution1 hit
16
The slide uses a 'call to action' style to advocate for structural corporate governance changes.Blackwells Capital | Activist Presentation Deck | 22 slides · Blackwells Capital
Activist deck Activist investor Beat · Solution1 hit
05
The chart uses a cohort analysis framework to visualize customer lifetime value progression.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide highlights the impact of an FLC accounting change on the reported growth rate.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide highlights the impact of an FLC accounting change on the growth rate.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The chart uses a break in the Q4 23 bar to visually represent the tax adjustment component.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations 1 hit
15
The slide highlights a specific accounting change (FLC) that impacted the margin by 40 bps.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations 1 hit
16
Includes a specific note regarding FLC accounting changes impacting Adjusted EBITDA margins.Coupang | Results Presentation Deck | 28 slides · Coupang
Conference presentation Investor relations 1 hit
10
The slide highlights influencer marketing and brand partnerships as key drivers for awareness.Crocs | Results Presentation Deck | 41 slides · Crocs
Conference presentation Investor relations Beat · Market Size1 hit
18
The slide uses a waterfall chart to illustrate capital usage and a list to detail RWA reduction progress.Deutsche Bank | Results Presentation Deck | 53 slides · Deutsche Bank
Conference presentation Investor relations Beat · ActionLoop · So What Cascade1 hit
34
Includes CAGR for 2021-2023 and YoY operating leverage metrics.Deutsche Bank | Results Presentation Deck | 53 slides · Deutsche Bank
Conference presentation Investor relations Beat · Action1 hit
11
Disney | Results Presentation Deck | 28 slidesDisney | Results Presentation Deck | 28 slides · Disney
Conference presentation Investor relations Loop · Logic Chain1 hit
01
Features Scrooge McDuck mascot; includes specific instructions to avoid voting for more than 12 nominees to prevent invalidation.Disney | Shareholder Engagement Presentation Deck | 8 slides · Disney
Activist deck Investor relations 1 hit
08
Includes footnotes for data sources and ROI methodology.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
13
Uses a Venn diagram to represent customer overlap between OSB, iGaming, and Lottery products.DraftKings | Results Presentation Deck | 23 slides · DraftKings
Conference presentation Investor relations Beat · Evidence1 hit
06
The slide details a specific corporate partnership deal structure.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Solution1 hit
07
The slide uses a two-column comparison layout to detail the EQUALISE and EQUATOR study statuses.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Solution1 hit
10
Uses a visual comparison framework to illustrate the 'Goldilocks' problem of cytokine inhibition (too narrow vs. too broad).Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Problem1 hit
11
The diagram uses a hub-and-spoke model to show how various scientific disciplines feed into the creation of 'Drug Products'.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
12
The slide highlights the commonality of the γC receptor subunit across different cytokine receptors, positioning it as a therapeutic target.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
17
The slide uses a four-column structure to explain the drug's mechanism, structure, preclinical results, and clinical status.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
18
The slide uses a structured comparison of four distinct disease areas to justify the market potential of the EQ101 franchise.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Market Size1 hit
19
The slide uses western blot data to demonstrate the mechanism of action difference between the competitor (Ruxolitinib) and the company's drug (EQ101).Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
20
Includes clinical trial data and visual evidence of skin improvement.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Traction1 hit
22
The diagram uses a circular flow/flywheel-like representation to show the disease cycle.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
23
Includes visual longitudinal study (Day 0, 14, 21) and a bar chart comparing PBS, Ruxolitinib, and EQ101.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
24
Data shows higher response rates for 4-mg dose and correlation between baseline severity and treatment efficacy.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
25
The slide uses a combination of qualitative physician sentiment and quantitative survey data to frame the problem of safety in current standard-of-care treatments.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
26
Includes definition of SALT score in footer.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit